The expression and clinical significance of CK20 and Ki-67 in transitional cell carcinoma of human bladder
Shan Chen
Abstract
Shan Chen
Abstract
Objective To study the expression of cytokeratin 20(CK20)and human nuclear antigen(Ki-67)in bladder transitional cell carcinoma as well as to evaluate their clinical significance.Methods Immunohistochemical method(Envosion)was used to evaluate the expreesion of CK20 in 66 patients and Ki-67 in 55 patients with bladder transitional cell carcinoma.Results The positive expression of CK20 in patients with bladder transitional cell carcinoma was 68.2%(45/66),which was statistically positive correlated with clinical stage and histological grade(P0.05).The positive expression of CK20 in recurrent cases was 92.3%(12/13),which was significantly higher than that in primary cases(62.3%)(33/53)(P0.05).The positive expression of Ki-67 in patients with bladder transitional cell carcinoma was 63.6%(35/55),which was statistically positive correlated with histological grade(P0.05).The positive expression in recurrent cases was 90.9%(10/11),which was significantly higher than that in primary cases(56.8%)(25/44)(P0.05).Conclusion The results suggested that expression of CK20 and Ki-67 in bladder transitional cell carcinoma are related to tumor biological behavior.Therefore,CK20 and Ki-67 can be useful markers of the stage,grade and prognosis of bladder transitional cell carcinoma.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To study the expression of cytokeratin 20(CK20)and human nuclear antigen(Ki-67)in bladder transitional cell carcinoma as well as to evaluate their clinical significance.Methods Immunohistochemical method(Envosion)was used to evaluate the expreesion of CK20 in 66 patients and Ki-67 in 55 patients with bladder transitional cell carcinoma.Results The positive expression of CK20 in patients with bladder transitional cell carcinoma was 68.2%(45/66),which was statistically positive correlated with clinical stage and histological grade(P0.05).The positive expression of CK20 in recurrent cases was 92.3%(12/13),which was significantly higher than that in primary cases(62.3%)(33/53)(P0.05).The positive expression of Ki-67 in patients with bladder transitional cell carcinoma was 63.6%(35/55),which was statistically positive correlated with histological grade(P0.05).The positive expression in recurrent cases was 90.9%(10/11),which was significantly higher than that in primary cases(56.8%)(25/44)(P0.05).Conclusion The results suggested that expression of CK20 and Ki-67 in bladder transitional cell carcinoma are related to tumor biological behavior.Therefore,CK20 and Ki-67 can be useful markers of the stage,grade and prognosis of bladder transitional cell carcinoma.
Key concepts: Medicine, Transitional cell carcinoma, Cytokeratin, Stage (stratigraphy), Immunohistochemistry, Clinical significance, Carcinoma, Bladder Neoplasm